<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04808700</url>
  </required_header>
  <id_info>
    <org_study_id>S57685</org_study_id>
    <nct_id>NCT04808700</nct_id>
  </id_info>
  <brief_title>Prospective Interventional Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant</brief_title>
  <official_title>Prospective Interventional Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lesions in the cartilage are common disorders. Arthroscopy lavage and debridement micro&#xD;
      fracturing, mosaic plasticity as well as osteochondral autograft transplantation (OATS) are&#xD;
      methods used for treatment of the lesions. Some have shown to help the patients but there is&#xD;
      an ongoing treatment gap especially for patients with knee lesions and early osteoarthritis.&#xD;
&#xD;
      Episurf Medical has developed a Focal Knee Resurfacing (FKR) implant, the Episealer® implant.&#xD;
      The implant is used for treatment of focal cartilage lesions of the lateral or medial femoral&#xD;
      condyle in order to alleviate pain and improve range of motion.&#xD;
&#xD;
      In this study, the investigators aims to establish if this implant is a viable option for&#xD;
      focal cartilage lesions of the distal femur not responding, or not eligible for, biological&#xD;
      treatment options (eg. microfracturing)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lesions in the cartilage are common disorders. In the knee, cartilage lesions are found in&#xD;
      over 50 % of all arthroscopies, where 25 % of these are of focal character and the majority&#xD;
      are found in the medial femoral condyle. The quality of life of patients with focal cartilage&#xD;
      defects is significantly affected and it has been shown that the quality of life is affected&#xD;
      to the same extend as in patients scheduled for knee replacement. Arthroscopy lavage and&#xD;
      debridement micro fracturing, mosaic plasticity as well as osteochondral autograft&#xD;
      transplantation (OATS) are methods used for treatment of the lesions. Some have shown to help&#xD;
      the patients but there is an ongoing treatment gap especially for patients with knee lesions&#xD;
      and early osteoarthritis.&#xD;
&#xD;
      Episurf Medical has developed a Focal Knee Resurfacing (FKR) implant, the Episealer® implant.&#xD;
      The implant is used for treatment of focal cartilage lesions of the lateral or medial femoral&#xD;
      condyle in order to alleviate pain and improve range of motion. The implant and surgical&#xD;
      instruments are customized to each patient's joint anatomy, position, and size of injury,&#xD;
      based on patient-specific images (MRI).&#xD;
&#xD;
      In this study, the investigators aims to establish if this implant is a viable option for&#xD;
      focal cartilage lesions of the distal femur not responding, or not eligible for, biological&#xD;
      treatment options (eg. microfracturing).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiographic and clinical evaluation</measure>
    <time_frame>within a time frame of 2 years</time_frame>
    <description>Survival of the implant up to 24 months post treatment with loss of the primary implant</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Focal Cartilage Lesions</condition>
  <arm_group>
    <arm_group_label>Focal cartilage lesion</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with focal cartilage lesions who underwent a knee surgery using the Episealer implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Follow-up of Episealer implant</intervention_name>
    <description>Follow-up and radiographic evaluation in patients who received an Episealer implant</description>
    <arm_group_label>Focal cartilage lesion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects with a focal cartilage lesion of the distal femur in which biological&#xD;
             surgical methods have failed or are not eligible&#xD;
&#xD;
          -  Minimal age of 18 years old (Preferred age group &gt;40 years)&#xD;
&#xD;
          -  Suitable for implant, to be determined by analysis of MRI imaging. Suitability is set&#xD;
             by the size and location of the lesion. The maximum size of the lesion is set at 6cm².&#xD;
&#xD;
          -  Informed consent obtained&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active or recent (&lt;1 yr) septic arthritis of the involved knee&#xD;
&#xD;
          -  Associated symptomatic untreated ligamentary or meniscal pathology in the involved&#xD;
             knee&#xD;
&#xD;
          -  (Severe) osteoarthritis in the involved or other compartments of the involved knee&#xD;
&#xD;
          -  Severe osteoporosis&#xD;
&#xD;
          -  MRI not possible (eg. due to pacemaker)&#xD;
&#xD;
          -  Marked valgus- or varus alignment (&gt;6 degrees)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hilde Vandenneucker</last_name>
    <phone>+32 16 33 88 23</phone>
    <email>hilde.vandenneucker@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 17, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cartilage lesions</keyword>
  <keyword>Episealer implant</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

